Recent Finacing
Recent Raise
EnEvolv uses a proprietary MAGE-based genome engineering platform to develop and license microorganisms producing chemicals, enzymes and small molecules for pharmaceuticals, personal care, food, specialty chemicals and energy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor